Encompass Health Corporation $EHC Shares Sold by Jensen Investment Management Inc.

Jensen Investment Management Inc. lowered its holdings in shares of Encompass Health Corporation (NYSE:EHC) by 12.0% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 50,660 shares of the company’s stock after selling 6,900 shares during the period. Jensen Investment Management Inc.’s holdings in Encompass Health were worth $6,435,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in the stock. Tectonic Advisors LLC increased its stake in Encompass Health by 1.6% in the 3rd quarter. Tectonic Advisors LLC now owns 5,337 shares of the company’s stock valued at $678,000 after purchasing an additional 82 shares in the last quarter. Global Retirement Partners LLC increased its position in Encompass Health by 23.0% during the third quarter. Global Retirement Partners LLC now owns 449 shares of the company’s stock worth $57,000 after purchasing an additional 84 shares during the last quarter. EP Wealth Advisors LLC boosted its holdings in shares of Encompass Health by 2.4% in the 2nd quarter. EP Wealth Advisors LLC now owns 3,694 shares of the company’s stock valued at $453,000 after purchasing an additional 88 shares during the last quarter. Natural Investments LLC grew its stake in shares of Encompass Health by 1.2% during the 3rd quarter. Natural Investments LLC now owns 7,808 shares of the company’s stock valued at $991,000 after buying an additional 89 shares during the period. Finally, TD Private Client Wealth LLC raised its holdings in shares of Encompass Health by 1.1% in the 3rd quarter. TD Private Client Wealth LLC now owns 8,216 shares of the company’s stock worth $1,044,000 after purchasing an additional 91 shares during the period. 97.25% of the stock is owned by institutional investors and hedge funds.

Encompass Health Stock Up 2.6%

Shares of Encompass Health stock opened at $108.90 on Wednesday. The stock has a market capitalization of $10.96 billion, a price-to-earnings ratio of 19.66, a PEG ratio of 2.05 and a beta of 0.73. Encompass Health Corporation has a twelve month low of $92.53 and a twelve month high of $127.99. The company has a current ratio of 1.08, a quick ratio of 1.14 and a debt-to-equity ratio of 0.76. The business’s 50 day simple moving average is $103.99 and its 200-day simple moving average is $114.50.

Encompass Health (NYSE:EHC) last issued its quarterly earnings data on Thursday, February 5th. The company reported $1.46 EPS for the quarter, topping analysts’ consensus estimates of $1.29 by $0.17. The firm had revenue of $3.09 billion during the quarter, compared to the consensus estimate of $1.54 billion. Encompass Health had a return on equity of 18.20% and a net margin of 9.54%.The firm’s revenue was up 9.9% on a year-over-year basis. During the same period in the prior year, the business earned $1.17 EPS. Encompass Health has set its FY 2026 guidance at 5.810-6.100 EPS. Equities research analysts forecast that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research firms have issued reports on EHC. Raymond James Financial upgraded shares of Encompass Health to a “strong-buy” rating in a research note on Friday, October 31st. Wall Street Zen upgraded Encompass Health from a “hold” rating to a “buy” rating in a research note on Sunday, January 18th. Zacks Research downgraded Encompass Health from a “strong-buy” rating to a “hold” rating in a report on Wednesday, November 19th. Finally, Barclays upped their price target on Encompass Health from $150.00 to $153.00 and gave the company an “overweight” rating in a research report on Friday. Two equities research analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, Encompass Health presently has a consensus rating of “Buy” and an average target price of $143.29.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.